Gencor self-affirms GRAS status for fenugreek extract

- Last updated on GMT

© iStock/Ezergil
© iStock/Ezergil

Related tags: Testosterone

Botanical ingredient supplier Gencor has announced that its standardized Fenugreek extract has been affirmed generally recognized as safe (GRAS) by an independent panel of toxicologists.

The company sells the extract of fenugreek (Trigonella foenumgraecum​) under the brand names Testofen and Libifem. Libifem (positioned for women) has been on the market for several years, while Testofen (positioned for men) has been on the market for over 10 years.

The self-affirmation supports a daily dose of 622.5 mg for a range of food and beverage applications, including: cereal bars; non-alcoholic beverages; fats and oils; dairy products / analogues; and processed fruit, vegetables and juices. (As a dietary supplement, intended intake is 600 mg per day.)

The ingredients are supported by clinical trials:
For example, findings of a double-blind, randomized, placebo-controlled trial, published in The Aging Male​ (2016, Vol. 19, No. 2, pp 134-142) reported that Testofen may reduce symptoms of age-related androgen decrease and boost testosterone levels in middle aged and older men.

Data from a double-blind randomized placebo controlled study with 80 women aged between 20 and 49 found that Libifem was associated with significant increases in measures of sexual cognition, arousal, sexual behavior, sexual drive, and orgasm (Phytotherapy Research​, 2015, Vol. 29, No. 8, pp. 1123–1130).

Related news

Related products

show more

Expand Your Portfolio with EpiCor

Expand Your Portfolio with EpiCor

Embria Health Sciences | 20-Jan-2020 | Research Study

The next movement in consumer health is fermentation. And as the first-of-its-kind fermentate ingredient that taps the natural power of fermentation to...

Related suppliers

Follow us

Featured Events

View more


View more